Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Randomized Controlled Phase 2a Study of RPh201 in Previous Nonarteritic Anterior Ischemic Optic Neuropathy.

Rath EZ, Hazan Z, Adamsky K, Solomon A, Segal ZI, Levin LA.

J Neuroophthalmol. 2019 Sep;39(3):291-298. doi: 10.1097/WNO.0000000000000786.

PMID:
31430268
2.

A First-in-Human Phase 1 Randomized Single and Multiple Ascending Dose Study of RPh201 in Healthy Volunteers.

Hazan Z, Adamsky K, Lucassen A, Levin LA.

Clin Pharmacol Drug Dev. 2019 Jun 28. doi: 10.1002/cpdd.720. [Epub ahead of print]

PMID:
31250992
3.

Toxicity and Toxicokinetic Study of Subcutaneously Administered RPh201 in Minipigs.

Ramot Y, Hazan Z, Lucassen A, Adamsky K, Ross V, Young N, Saunders M, Ehall H, Nyska A.

Toxicol Pathol. 2018 Aug;46(6):693-705. doi: 10.1177/0192623318786428. Epub 2018 Jul 15.

PMID:
30009686
4.

Toxicity and toxicokinetic study of RPh201 in Sprague-Dawley rats.

Ramot Y, Hazan Z, Lucassen A, Adamsky K, Santhosh Kumar DP, Vijayasarathi SK, Krishnappa H, Seervi MS, Nyska A.

Food Chem Toxicol. 2018 Feb;112:168-177. doi: 10.1016/j.fct.2017.12.036. Epub 2017 Dec 27.

PMID:
29288761
5.

Caspr and caspr2 are required for both radial and longitudinal organization of myelinated axons.

Gordon A, Adamsky K, Vainshtein A, Frechter S, Dupree JL, Rosenbluth J, Peles E.

J Neurosci. 2014 Nov 5;34(45):14820-6. doi: 10.1523/JNEUROSCI.3369-14.2014.

6.

Identification of Tmem10/Opalin as an oligodendrocyte enriched gene using expression profiling combined with genetic cell ablation.

Golan N, Adamsky K, Kartvelishvily E, Brockschnieder D, Möbius W, Spiegel I, Roth AD, Thomson CE, Rechavi G, Peles E.

Glia. 2008 Aug 15;56(11):1176-86. doi: 10.1002/glia.20688.

7.

Altered adenosine-to-inosine RNA editing in human cancer.

Paz N, Levanon EY, Amariglio N, Heimberger AB, Ram Z, Constantini S, Barbash ZS, Adamsky K, Safran M, Hirschberg A, Krupsky M, Ben-Dov I, Cazacu S, Mikkelsen T, Brodie C, Eisenberg E, Rechavi G.

Genome Res. 2007 Nov;17(11):1586-95. Epub 2007 Oct 1.

8.

Hepcidin, a key regulator of iron metabolism, is transcriptionally activated by p53.

Weizer-Stern O, Adamsky K, Margalit O, Ashur-Fabian O, Givol D, Amariglio N, Rechavi G.

Br J Haematol. 2007 Jul;138(2):253-62.

PMID:
17593032
9.

A central role for Necl4 (SynCAM4) in Schwann cell-axon interaction and myelination.

Spiegel I, Adamsky K, Eshed Y, Milo R, Sabanay H, Sarig-Nadir O, Horresh I, Scherer SS, Rasband MN, Peles E.

Nat Neurosci. 2007 Jul;10(7):861-9. Epub 2007 Jun 3.

10.

Apaf1 in chronic myelogenous leukemia (CML) progression: reduced Apaf1 expression is correlated with a H179R p53 mutation during clinical blast crisis.

Ashur-Fabian O, Adamsky K, Trakhtenbrot L, Cohen Y, Raanani P, Hardan I, Nagler A, Rechavi G, Amariglio N.

Cell Cycle. 2007 Mar 1;6(5):589-94. Epub 2007 Mar 23.

PMID:
17361096
11.

P53 in blind subterranean mole rats--loss-of-function versus gain-of-function activities on newly cloned Spalax target genes.

Avivi A, Ashur-Fabian O, Joel A, Trakhtenbrot L, Adamsky K, Goldstein I, Amariglio N, Rechavi G, Nevo E.

Oncogene. 2007 Apr 12;26(17):2507-12. Epub 2006 Oct 16.

PMID:
17043642
12.

Downregulation of hepcidin and haemojuvelin expression in the hepatocyte cell-line HepG2 induced by thalassaemic sera.

Weizer-Stern O, Adamsky K, Amariglio N, Levin C, Koren A, Breuer W, Rachmilewitz E, Breda L, Rivella S, Cabantchik ZI, Rechavi G.

Br J Haematol. 2006 Oct;135(1):129-38. Epub 2006 Aug 25.

PMID:
16939499
13.

mRNA expression of iron regulatory genes in beta-thalassemia intermedia and beta-thalassemia major mouse models.

Weizer-Stern O, Adamsky K, Amariglio N, Rachmilewitz E, Breda L, Rivella S, Rechavi G.

Am J Hematol. 2006 Jul;81(7):479-83.

14.

Identification of novel cell-adhesion molecules in peripheral nerves using a signal-sequence trap.

Spiegel I, Adamsky K, Eisenbach M, Eshed Y, Spiegel A, Mirsky R, Scherer SS, Peles E.

Neuron Glia Biol. 2006 Feb;2(1):27-38.

15.

Exploring the role of hepcidin, an antimicrobial and iron regulatory peptide, in increased iron absorption in beta-thalassemia.

Breda L, Gardenghi S, Guy E, Rachmilewitz EA, Weizer-Stern O, Adamsky K, Amariglio N, Rechavi G, Giardina PJ, Grady RW, Rivella S.

Ann N Y Acad Sci. 2005;1054:417-22.

PMID:
16339690
16.

Role of iron in inducing oxidative stress in thalassemia: Can it be prevented by inhibition of absorption and by antioxidants?

Rachmilewitz EA, Weizer-Stern O, Adamsky K, Amariglio N, Rechavi G, Breda L, Rivella S, Cabantchik ZI.

Ann N Y Acad Sci. 2005;1054:118-23. Review.

PMID:
16339657
17.

Identification of RNA editing sites in the SNP database.

Eisenberg E, Adamsky K, Cohen L, Amariglio N, Hirshberg A, Rechavi G, Levanon EY.

Nucleic Acids Res. 2005 Aug 12;33(14):4612-7. Print 2005.

18.

Suppressors of cytokine signaling 4 and 5 regulate epidermal growth factor receptor signaling.

Kario E, Marmor MD, Adamsky K, Citri A, Amit I, Amariglio N, Rechavi G, Yarden Y.

J Biol Chem. 2005 Feb 25;280(8):7038-48. Epub 2004 Dec 7.

19.

Evolution of p53 in hypoxia-stressed Spalax mimics human tumor mutation.

Ashur-Fabian O, Avivi A, Trakhtenbrot L, Adamsky K, Cohen M, Kajakaro G, Joel A, Amariglio N, Nevo E, Rechavi G.

Proc Natl Acad Sci U S A. 2004 Aug 17;101(33):12236-41. Epub 2004 Aug 9.

20.

Decreased hepcidin mRNA expression in thalassemic mice.

Adamsky K, Weizer O, Amariglio N, Breda L, Harmelin A, Rivella S, Rachmilewitz E, Rechavi G.

Br J Haematol. 2004 Jan;124(1):123-4. No abstract available.

PMID:
14675418
21.
22.
23.

Specific gene expression in pancreatic beta-cells: cloning and characterization of differentially expressed genes.

Arava Y, Adamsky K, Ezerzer C, Ablamunits V, Walker MD.

Diabetes. 1999 Mar;48(3):552-6.

PMID:
10078555
24.

Differential expression of the protein kinase A regulatory subunit (RIalpha) in pancreatic endocrine cells.

Arava Y, Adamsky K, Belleli A, Shaltiel S, Walker MD.

FEBS Lett. 1998 Mar 20;425(1):24-8.

Supplemental Content

Loading ...
Support Center